EMA Launches New Safety Review of Prenatal Valproate Exposure – Medscape
Medscape |
EMA Launches New Safety Review of Prenatal Valproate Exposure
Medscape A new safety review has been launched by the European Medicines Agency (EMA) into the use of valproate by women who are already pregnant or are of childbearing age, the agency announced today. Its Pharmacovigilance and Risk Assessment … |
Read Original Article: EMA Launches New Safety Review of Prenatal Valproate Exposure – Medscape »
Powered by WPeMatico
